Dapagliflozin + Bisoprolol Tablet Franchise in Ahmedabad

Cardio-Diabetic Care Tablet Supplier in Mumbai

Diabetes & Cardiac Medicine Distributor in Delhi

Cardio-Diabetic Pharma Franchise in Bangalore

Dapagliflozin Bisoprolol Tablet Stockist in Hyderabad
Cardio-Diabetic Tablet Manufacturer & Exporter in Chandigarh

Home/Products /dapagliflozin-10mg-bisoprolol-10mg-tablet

About the Product

Description


Dapoflit B 10 Tablet contains Dapagliflozin 10mg + Bisoprolol 10mg, a dual-action therapy designed for patients managing diabetes along with cardiovascular conditions. Dapagliflozin improves glycemic control by promoting glucose excretion, while Bisoprolol supports heart rate regulation and cardiac stability.

This tablet is increasingly preferred by prescribers due to its combined metabolic and cardiac benefits, making it suitable for long-term therapy. Patients experience improved glucose control, better cardiovascular support, and enhanced treatment compliance.

From a business perspective, this combination addresses the rapidly growing cardio-diabetic segment, where long-term prescriptions and repeat demand are common. Its strong therapeutic relevance ensures consistent movement across retail and institutional channels.

With rising prevalence of diabetes-linked heart conditions, Dapoflit B 10 Tablet offers excellent market sustainability and portfolio strength, helping partners build credibility and long-term growth in the cardio-diabetic care segment.

Common side effects may include dizziness, fatigue, headache, increased urination, and mild gastrointestinal discomfort. Some patients may experience low blood pressure, slow heart rate, or urinary tract infections. Any severe symptoms such as fainting, persistent weakness, or signs of infection should be reported immediately to a healthcare professional.

Dapoflit B 10 Tablet is indicated for the management of type 2 diabetes mellitus in patients with associated hypertension or cardiovascular disease. It is also useful in patients requiring blood pressure control along with added cardioprotective benefits.

Dapoflit B 10 Tablet should be taken strictly as prescribed by a physician. Regular monitoring of blood glucose levels, blood pressure, kidney function, and heart rate is recommended. Caution is advised in patients with kidney impairment, dehydration, or heart conduction disorders. Do not discontinue the medication abruptly without medical advice.

Store Dapoflit B 10 Tablet in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date mentioned on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Dapagliflozin 10mg + Bisoprolol 10mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the cardiology and diabetes management segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include this tablet in their product range?

Medical distributors and wholesalers can benefit from consistent demand in patients with diabetes, heart failure, hypertension, and cardio-metabolic disorders. It strengthens their cardiology and chronic care portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this combination tablet?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dapagliflozin 10mg + Bisoprolol 10mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this cardiometabolic tablet?

Wholesalers and medical agencies benefit from strong chronic disease market demand, long-term prescriptions, and stable recurring sales when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this cardiometabolic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.